GE HealthCare tops Q3 forecasts and raises full-year outlook, shares jump 8%
What happened
GE HealthCare posted third-quarter earnings per share of $1.34, up 25% year over year and 14 cents ahead of consensus, on revenue of $5.513 billion, up 7.2% and $162 million above estimates. CEO Peter Arduini cited 'strong top-line growth and margin expansion across all segments.' Overall EBIT margin rose to 16.6% from 14.8%, helped by a 0.9% reduction in the tariff rate, and backlog climbed to $23.7 billion on a 1.03 book-to-bill ratio. The company raised its full-year earnings outlook to $4.95-$5.05 from $4.80-$5.00, its strongest earnings growth since the 2023 spinoff, and shares jumped about 7-8% in early Wednesday trading, toward a buy point above 75.65.
Why it matters & what’s next are part of Pro, along with the audio summary.
Start your free 14-day trialWho’s affected & sources
Who’s affected
- GE HealthCare (GEHC) — direct beneficiary; med-tech peers and health-care equipment names may get a sentiment lift; a breakout above its 75.65 buy point could draw momentum buyers.